NAD-boosting supplements have a strong scientific story behind them — but the leap from “raises NAD levels in blood” to “transforms your health” isn’t well-supported by the human evidence. Here’s an honest breakdown of what the trials actually show, what’s promising but unproven, and what’s mostly marketing.
For background, see NAD+ and what is NAD.
1. Reliably raises blood NAD levels (well-established)
This is the most-replicated finding. Both nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) supplementation increases NAD levels in blood and tissues, dose-dependently.
Lose weight
Gain muscles
Eat healthy
Explore new cuisines
Linda P.
Available on the App StoreA 2022 randomized trial of 80 healthy middle-aged adults found 300, 600, and 900 mg/day NMN all raised blood NAD significantly over 60 days — with the highest levels at 600 and 900 mg.1 Multiple other human trials of NR confirm similar increases.2
Why this matters: it confirms the supplements actually work mechanistically. What raised NAD does in your body is the next question.
2. Improved physical performance in middle-aged adults
The 2022 NMN trial measured a six-minute walking test as a functional outcome. All NMN dose groups (300, 600, 900 mg/day) showed significantly improved walking distance vs. placebo at days 30 and 60.1 Improvements were largest in the 600 and 900 mg groups.
This is one of the cleaner functional benefit signals across NAD-precursor research. It’s not transformative — middle-aged adults walking somewhat farther — but it’s measurable.
3. Improved subjective health and energy
The same 2022 trial measured the SF-36 health questionnaire, a validated subjective health assessment. All three NMN doses produced significantly better scores at day 60 vs. placebo.1 Some participants reported improvements in energy, sleep quality, and general well-being.
Subjective improvements without objective markers are easy to dismiss as placebo, but the SF-36 has decades of use as a credible health-status measure.
4. Possible improvements in cardiovascular and metabolic markers
Smaller trials have shown:
- Modest improvements in blood pressure
- Improved arterial stiffness measures
- Better insulin sensitivity in some metabolically compromised populations
- Improved cholesterol markers
The effects are typically modest and don’t replace established cardiovascular interventions (statins, blood pressure medications, weight management).
5. Generally clean safety profile
Both NMN and NR have shown good safety in human trials at doses up to 900 mg/day for NMN1 and 1,000 mg/day for NR.2 Adverse events have been mild and infrequent — mostly GI upset, headaches in a small percentage.
Long-term human safety data (years) is limited, but no major signals have emerged from the studies completed so far.
A 2022 review on NMN as an anti-aging product confirmed the safety profile while emphasizing that more long-term human research is still needed.3
6. Possible age-related “biological age” markers
The 2022 NMN trial used the Aging.Ai 3.0 calculator to estimate “blood biological age.” The placebo group’s biological age increased over the 60-day period, while the NMN-treated groups stayed unchanged — producing a significant difference.1
Biological age algorithms are still imperfect tools, but they’re what longevity researchers currently have.
What’s promising but unproven
Several effects show up in animal studies but lack robust human evidence:
Cognitive enhancement
Animal studies show NAD precursors improve cognition in older mice. Human trials in healthy adults are sparse and inconsistent. Better evidence in specific clinical conditions (e.g., Friedreich’s ataxia) than in general aging.
Skin aging effects
Some topical and oral applications claim skin benefits. Limited human RCT evidence.
Suggested read: NAD Injections: Do They Work? An Honest Guide
DNA repair improvements
Mechanistically plausible (PARPs use NAD for DNA repair), but functional human outcomes are limited.
Cellular senescence reduction
Animal data suggests NAD precursors may reduce senescent cell accumulation. Human evidence isn’t there yet.
Immune function improvements
Some early signals; not robust.
What’s mostly marketing
Three claims worth pushing back on:
“Reverses aging”
NAD precursors raise NAD levels. They don’t reverse aging in any meaningful clinical sense. The marketing language is well ahead of what the trials show.
“Restores youthful energy”
Some people feel modestly better. Most people don’t notice dramatic energy changes. If you’re going from 60-year-old physiology back toward 30-year-old physiology, NAD supplements aren’t doing that.
“Boosts longevity”
Animal lifespan extension data exists. Human lifespan data doesn’t and won’t for decades. Don’t take NAD with the expectation it will extend your life.
Specific populations who may benefit most
Based on the available data:
Middle-aged adults (40s–60s) experiencing age-related decline
The clearest signal. Improved walking distance, subjective health, and biological age markers.1
People with metabolic syndrome
Possible improvements in insulin sensitivity, lipid markers, and cardiovascular risk factors.
Athletes recovering from heavy training
Limited but promising evidence on muscle recovery and mitochondrial function.
People with specific clinical conditions
NAD precursors are being studied in Parkinson’s, ALS, Friedreich’s ataxia, post-COVID, and several other conditions. These uses should be guided by physicians, not self-prescribed.
Who probably won’t benefit
- Young, healthy adults with no specific symptoms — likely minimal noticeable effect
- People still doing the basics poorly — sleep, exercise, and diet matter more
- People expecting dramatic results — gentle, modest effects are the realistic expectation
- People with active cancer without medical guidance — theoretical concerns about cancer cell metabolism
How to test whether NAD works for you
A reasonable self-experiment:
- Baseline: Track sleep quality, daytime energy, exercise performance, and any symptoms over 2 weeks
- Trial: 600 mg NMN daily (or 500 mg NR daily) for 8–12 weeks
- Measure same outcomes
- Decide: Did anything actually change? Was it worth the cost?
Unlike many supplements, NAD precursors are expensive enough that this kind of decision-making matters.
Suggested read: Berberine Benefits: 7 Effects Backed by Research
Common questions
Is NMN better than NR? Both raise NAD. NMN has more recent positive trials; NR has more long-term human data. Effect sizes are roughly comparable.
Will NAD make me feel younger? Some people report subtle improvements. Most people don’t experience dramatic effects. Manage expectations.
How does NAD compare to other “longevity” supplements? NAD precursors have stronger mechanistic evidence than most. Strength of clinical outcome data is still modest compared to basic interventions like exercise and sleep.
Should I take NAD with niacin? Stacking different forms of NAD precursors isn’t shown to be additive. Pick one and run with it.
Do I need cycling (on/off) protocols? Not based on current evidence. Some practitioners recommend cycling; the published trials use continuous dosing.
Bottom line
NAD-boosting supplements deliver real measurable effects: raised blood NAD levels, modest improvements in physical performance and subjective health in middle-aged adults, possibly improved metabolic and cardiovascular markers, and a clean safety profile so far. They don’t reverse aging, restore youthful energy at the level marketed, or extend lifespan in any way human evidence has demonstrated. Reasonable to try if you’re already doing the basics well and want a small additional lever — not a primary intervention.
Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Geroscience. 2023;45(1):29-43. PubMed ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Mehmel M, Jovanović N, Spitz U. Nicotinamide Riboside-The Current State of Research and Therapeutic Uses. Nutrients. 2020;12(6):1616. PubMed ↩︎ ↩︎
Nadeeshani H, Li J, Ying T, Zhang B, Lu J. Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns. J Adv Res. 2022;37:267-278. PubMed ↩︎
Sarah M.
Linda P.
Maya T.
Marcus J.
Emma R.
Amanda K.
Chris B.
David L.
James W.
Jennifer S.
Kevin H.
Lisa C.
App Store ★★★★★
